MADISON, Wis., Jan. 8, 2026 /PRNewswire/ -- Elephas Biosciences Corporation (Elephas), a private company that has developed an innovative live tissue platform for immunotherapy response prediction, ...
MADISON, Wis., April 16, 2026 /PRNewswire/ -- Elephas Biosciences Corporation (Elephas), a private company that has developed the elive™ ex vivo tumor profiling platform, announced a scientific ...
Three Investigator-Initiated Trials (IITs) to utilize the Elephas Live™ Platform to evaluate the impact of a combination therapy of surgical intervention and immunotherapy MADISON, Wis., Feb. 23, 2026 ...
Subscribe to BizTimes Daily – Local news about the people, companies and issues that impact business in Milwaukee and Southeast Wisconsin. Elephas is developing an oncology diagnostics platform that ...
Elephas, an oncology-focused diagnostics platform, announced it secured $55 million in Series C funding, bringing its total raise to $116.5 million. Venture Investors Health Fund and the State of ...
Arch Venture Partners leads round to advance company's novel live tumor diagnostic platform MADISON, Wis., Sept. 6, 2022 /PRNewswire/ -- Elephas Biosciences Corporation (Elephas), a private company, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results